![]() |
市場調查報告書
商品編碼
1754009
2025 年至 2033 年光聲影像市場報告(按產品、適應症、應用、最終用途和地區)Photoacoustic Imaging Market Report by Product, Indication, Application, End Use, and Region 2025-2033 |
2024年,全球光聲成像市場規模達到1.09億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到3.17億美元,2025-2033年期間的複合年成長率(CAGR)為12.6%。市場成長主要得益於混合成像技術的不斷進步、光聲成像在腫瘤學中用於高解析度腫瘤可視化的廣泛應用,以及為提高診斷準確性和探索新的臨床應用而不斷增加的研發投入。
光聲成像,也稱為光聲成像,是一種非侵入性生物醫學成像技術,無需使用電離輻射即可捕捉生物組織影像。它是一種基於光聲效應的混合成像模式,將吸收的光能轉換為聲能。與傳統成像技術相比,它具有許多優勢,包括高穿透力、高深度和高影像解析度,無有害電離輻射,以及在成像深度上進行分子靶向。它可用於檢測生理特性和天然存在的髮色團,例如脂質、黑色素、血紅蛋白濃度以及水和氧飽和度。此外,它還廣泛用於腫瘤定位、腦功能、皮膚黑色素瘤檢測以及高鐵血紅蛋白測量。因此,光聲成像在全球範圍內正獲得巨大的發展。
成像系統的持續技術進步
光聲成像市場需求隨著成像技術的不斷發展而顯著成長。更先進的混合成像系統透過將光聲成像與光學和超音波方法相結合,提供更佳的功能成像和更高的解析度。這些發展使得即時可視化生物組織成為可能,並具有更好的深度穿透力和對比度,尤其適用於腫瘤學和心血管應用。透過先進的軟體和演算法實現影像重建和解讀的改進正受到大眾的青睞。最近的一項研究介紹了一種使用基於矽光子學的LDV的非接觸式光聲方法,其性能優於商用系統,並能重建精確的2D影像。這些技術創新使系統更加通用,推動了其在科研和臨床領域的應用,並支持了整體市場的成長。
腫瘤學領域的應用日益廣泛
這些影像解決方案在腫瘤學領域的應用日益廣泛,也促進了光聲成像市場的成長。該技術能夠提供腫瘤血管和組織氧合水平的高解析度影像,這對於早期癌症檢測、追蹤治療反應和指導手術具有重要意義。對於需要反覆掃描的患者,非侵入式光聲影像比CT和MRI等傳統影像方式更安全。隨著全球癌症發生率的上升,更精確的即時診斷儀器正變得越來越受歡迎。
增加研發投入
由於研發支出不斷成長,市場擴張速度加快,光聲成像市場佔有率也隨之擴大。為了改善患者預後和診斷準確性,企業和研究機構正致力於開發影像系統並探索新的臨床應用。快速開發新型造影劑以增強某些組織和疾病的影像效果是這些努力的另一個目標。除了核心技術的進步外,政府資金以及產學研戰略合作也進一步支持了該領域的持續創新。因此,研發工作正在拓寬光聲成像的潛在用途,推動各種醫療和研究領域的需求,並增強光聲成像市場分析。
The global photoacoustic imaging market size reached USD 109 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 317 Million by 2033, exhibiting a growth rate (CAGR) of 12.6% during 2025-2033. The market growth is primarily driven by the ongoing advancements in hybrid imaging technologies, the expanding use of photoacoustic imaging in oncology for high-resolution tumor visualization, and rising investments in research and development to improve diagnostic accuracy and explore new clinical applications.
Photoacoustic imaging, also known as optoacoustic imaging, is a non-invasive biomedical imaging technique that captures images of biological tissues without using ionizing radiation. It is a hybrid modality that functions on the photoacoustic effect, wherein absorbed optical energy is converted into acoustic energy. It offers various advantages over conventional imaging techniques, including high penetration, depth, and image resolution, no harmful ionizing radiation, and molecular targeting at imaging depth. It is employed in detecting physiological properties and naturally occurring chromophores, such as lipids, melanin, hemoglobin concentration, and water and oxygen saturation. Besides this, it is extensively used for tumor mapping, functioning of the brain, detecting skin melanoma, and measuring methemoglobin. As a result, photoacoustic imaging is gaining immense traction across the globe.
Continual Technological Advancements in Imaging Systems
According to the photoacoustic imaging market, the demand is increasing significantly due to ongoing developments in imaging technology. More advanced hybrid imaging systems are offering improved functional imaging and higher resolution through the combination of photoacoustic imaging with optical and ultrasonic approaches. These developments render it possible to visualize biological tissues in real time with better depth penetration and contrast, especially for oncology and cardiovascular applications. Improved image reconstruction and interpretation through advanced software and algorithms are being preferred by the masses. A recent study introduced a non-contact photoacoustic method using a silicon photonics based LDV, which outperformed commercial systems and reconstructed accurate 2D images. These technological innovations are making the systems more versatile, driving their adoption in both research and clinical settings, and supporting the overall market growth.
Growing Application in Oncology
The increasing application of these imaging solutions in oncology is also contributing to the photoacoustic imaging market growth. Its ability to provide high-resolution images of tumor vasculature and tissue oxygenation levels renders the technique invaluable for early cancer detection, tracking treatment response, and guiding surgery. For patients who need repeated scans, non-invasive photoacoustic imaging is a safer option than conventional imaging modalities such as CT and MRI. More precise, real-time diagnostic instruments are becoming increasingly popular as the prevalence of cancer rises worldwide.
Increasing Research and Development Investments
The market is expanding more quickly as a result of the growing research and development (R&D) expenditures, thereby augmenting the photoacoustic imaging market share. In order to improve patient outcomes and diagnostic accuracy, businesses and research institutes are concentrating on developing imaging systems and investigating novel clinical applications. The rapid development of novel contrast agents enhancing the imaging of certain tissues and disorders is another goal of these efforts. In addition to the advancement of core technologies, ongoing innovation in this field is also being further supported by government financing and strategic collaborations between industry and academics. Consequently, research and development endeavors are broadening the possible uses of photoacoustic imaging, propelling demand in diverse medical and research domains, and augmenting photoacoustic imaging market analysis.